You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Opioid Induced Constipation Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

According to 99Strategy, the Global Opioid Induced Constipation Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Opioid Induced Constipation Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Ironwood Pharmaceuticals Inc 
Daiichi Sankyo Co Ltd 
Pfizer 
Progenics Pharmaceuticals Inc 
Shionogi & Co., Ltd 
Allergan Plc 
Nektar Therapeutics 
Purdue Pharma 
S.L.A. Pharma AG 
Mundipharma International Limited 
Ono Pharmaceutical Co., Ltd 
Takeda Pharmaceutical Company Limited 
Theravance Biopharma Inc 
Valeant Pharmaceuticals International 
Cosmo Pharmaceuticals SA 
Daewoong Pharmaceutical 
C.B. Fleet Company 
Sucampo Pharmaceuticals
Key Product Type
Lubiprostone 
Methyl Naltrexone Bromide 
Naldemedine 
Alvimopan 
Others
Market by Application
Hospital Pharmacies 
Retail Pharmacies 
Online Pharmacies
Main Aspects covered in the Report
Overview of the Opioid Induced Constipation Drugs market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Table of Content
1 Industrial Chain Overview
1.1 Opioid Induced Constipation Drugs Industry
1.1.1 Overview
Figure Opioid Induced Constipation Drugs Picture List
1.1.2 Characteristics of Opioid Induced Constipation Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Lubiprostone 
1.3.2 Methyl Naltrexone Bromide 
1.3.3 Naldemedine 
1.3.4 Alvimopan 
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Hospital Pharmacies 
1.4.2 Demand in Retail Pharmacies 
1.4.3 Demand in Online Pharmacies
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 Ironwood Pharmaceuticals Inc  Overview
Table Ironwood Pharmaceuticals Inc  Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Daiichi Sankyo Co Ltd  Overview
Table Daiichi Sankyo Co Ltd  Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Daiichi Sankyo Co Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Pfizer  Overview
Table Pfizer  Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Pfizer  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Progenics Pharmaceuticals Inc  Overview
Table Progenics Pharmaceuticals Inc  Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Shionogi & Co., Ltd  Overview
Table Shionogi & Co., Ltd  Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Shionogi & Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Allergan Plc  Overview
Table Allergan Plc  Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Allergan Plc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Nektar Therapeutics  Overview
Table Nektar Therapeutics  Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Nektar Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Purdue Pharma  Overview
Table Purdue Pharma  Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Purdue Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 S.L.A. Pharma AG  Overview
Table S.L.A. Pharma AG  Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of S.L.A. Pharma AG  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Mundipharma International Limited  Overview
Table Mundipharma International Limited  Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Mundipharma International Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Ono Pharmaceutical Co., Ltd  Overview
Table Ono Pharmaceutical Co., Ltd  Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Ono Pharmaceutical Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Takeda Pharmaceutical Company Limited  Overview
Table Takeda Pharmaceutical Company Limited  Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Takeda Pharmaceutical Company Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Theravance Biopharma Inc  Overview
Table Theravance Biopharma Inc  Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Theravance Biopharma Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Valeant Pharmaceuticals International  Overview
Table Valeant Pharmaceuticals International  Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Valeant Pharmaceuticals International  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Cosmo Pharmaceuticals SA  Overview
Table Cosmo Pharmaceuticals SA  Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Daewoong Pharmaceutical  Overview
Table Daewoong Pharmaceutical  Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Daewoong Pharmaceutical  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 C.B. Fleet Company  Overview
Table C.B. Fleet Company  Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of C.B. Fleet Company  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Sucampo Pharmaceuticals Overview
Table Sucampo Pharmaceuticals Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Lubiprostone 
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Lubiprostone , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Lubiprostone , 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Methyl Naltrexone Bromide 
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2017-2021, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Naldemedine 
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Naldemedine , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Naldemedine , 2017-2021, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Alvimopan 
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Alvimopan , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Alvimopan , 2017-2021, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Hospital Pharmacies 
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Retail Pharmacies 
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Online Pharmacies
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2017-2021, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Opioid Induced Constipation Drugs Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion